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Once activated by agents such as IFN-y and bacterial LPS, macrophages (MO)t
can inhibit the growth ofa wide variety of tumor and microbial targets (1, 2) . Al-
thoughMO products such as hydrogen peroxide, TNFa, and IL-1 cause cytostasis
and/or cytotoxicity (3-5), in many cases these mediators do not appear to be in-
volved . With some targets, Mo-mediated cytostasis and injury to the mitochondria)
electron transport chain (METC) require a process associated with MO oxidation
of the guanido nitrogens of L-arginine to N02 -/NO3 - (6). However, it is unknown
if a metabolite of L-arginine causes these injuries, and if so, which metabolite.
Activated Mo have recently been shown to release a compound similar to or iden-
tical with the reactive radical nitric oxide (NO .) during metabolism of L-arginine
to N02 -/NO3 - (7) . This report identifies NO . (or a closely related product) as a
mediator ofMO-induced cytostasis and mitochondria) respiratory inhibition in lym-
phoma cells .
Materials and Methods
Reagents.
￿
Cells were cultured in minimum Eagle's medium, a modification (aMEM) or
RPMI 1640 (RPMI ; KC Biological Inc ., Lenexa, KS), both supplemented with 8% bovine
calf serum (CS; HyClone Systems, Logan, UT), L-glutamine (584 mg/liter), penicillin (50
U/ml), and streptomycin (50 pg/ml) . Catalase and N°-monomethyl-L-arginine (NMA) were
from Calbiochem-Behring Corp. La Jolla, CA. NO . gas (99% pure) and N2 gas (45 ppm
02) were from Matheson Gas Products, East Rutherford, NJ . [Methyl- 3H]TdR (2 Ci/mmol)
was from New England Nuclear, Boston,MA . Pure IFN-y was generously provided by Genen-
tech, South San Francisco, CA . LPS (Escherichia coli serotype 0127 : B8) and all other reagents
were from Sigma Chemical Co., St . Louis, MO. Concentrated stock solutions were prepared
in culture medium (for myoglobin, ascorbate, catalase, NMA, LPS, and IFN-y) or saline
(for NaN02, NaN03, FeS04) and sterile filtered (0.22 pm, Millipore, Danvers, MA) .
Collection and Culture ofMouse PeritonealMo and L1210 Cells.
￿
Peritoneal Mo were obtained
fromC3H/HeJ (TheJackson Laboratories, Bar Harbor, ME), C3H/He, orCD-1 mice (Charles
River Breeding Laboratories, Wilmington, MA) that had been injected 4 d previously with
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2 ml of 4% Brewer's thioglycollate broth (Difco Laboratories, Detroit, MI) by peritoneal la-
vage with PBS containing 25 mM glucose. The cells were pelleted at 4°C, resuspended in
ciMEM to 106/ml, and plated at 0 .1 or 1 ml/well in 96- or 24-well plates, respectively. After
culture for 2-3 h at 37°C in 5% C02 , the medium was aspirated and replaced with an equal
volume ofctMEM, which in some cases contained 500 U/ml IFN-,y to activate the MO. L1210
cells (American Type Culture Collection, Rockville, MD) were kept in continuous culture
in RPMI 1640.
MO-L1210 Cell Coculture.
￿
After MO were cultured overnight in 96-well plates, the medium
was aspirated and replaced with 50 pl uMEM containing no added LPS (control MO) or
3 leg/ml LPS (activated MO). L1210 cells (5 x 104/well, 25 pl) were then added along with
solutions containing experimental agents and the volume of each well brought to 150 l l with
aMEM. After 6 h, 2.5 hCi [3H]TdR was added to each well for a period lasting 12-18 h.
In some cases, 50 pl volumes were removed from the cocultures at this point to measure
N02- production. Each experiment had control wells consisting of L1210 cells cultured
without Mo under each experimental condition; L1210 [3H]TdR incorporation was
unaffected by the additives in all cases. For experiments in Table II, 1.5 x 10' MO were plated
in 100-mm culture dishes and in some cases activated overnight with IFN-y as described for
the 96-well experiments. The next day the medium was replaced with medium ± LPS or
LPS and 250 p.M NMA. L1210 cells were added (2 x 106/plate), cocultured for 24 h, and
removed from the monolayers by rinsing with a pipette. The L1210 cells were counted and
plated at 5 x 104/well for [3H]TdR incorporation studies.
Culture of L1210 Cells with N02 at ReducedpH.
￿
L1210 cells (2 x 106/ml) were cultured
without C02 in a 370C incubator in bicarbonate-free DME containing 2 0 /0 CS, 20 mM
Hepes, 20 mM morpholinoethane sulfonate, and various concentrations of NaN02 or
NaN03 . Solutions were prepared fresh for each experiment, the pH adjusted to range from
6.2 to 7 .2 with 1 M NaOH, and were sterile filtered through a 0 .22-Am membrane. After
culture for various times, the cells were pelleted and resuspended in conventional RPMI (pH
7.2) at 2 x 106/ml and plated at 5 x 104/well. Viabilities at this point ranged between 77
and 90% by trypan blue exclusion. [3H]TdR was added and its incorporation was measured
over an 18-h period.
Treatment ofL1210 Cells with N0. -saturated Solutions.
￿
For 02 consumption studies solutions
of saline (10 ml) containing 25 mM glucose were bubbled with N2 for 45 min to remove dis-
solved 02 . Authentic NO- that had passed through 1 M KOH to remove nitrogen dioxide
(N02) was then bubbled in for 15-20 min to form saturated solutions ([NO.] = 1.25 mM;
reference 8). Various volumes were transferred with a gas-tight syringe into stoppered N2-
flushed tubes containing L1210 cells (4 x 10' to 4 x 108) suspended in 0.1 ml CS and the
contents were mixed. After 5 min on ice, 2 ml ofcold, aerated RPMI was added to destroy
the remaining NO- . The cells were centrifuged and resuspended to 5 x 108/ml in the respi-
ration medium used for intact cells (see below). Cell viabilities at this point were >_80To (trypan
blue dye exclusion). For controls, the NO- solutions were first sparged with N2 for 15 min
and then with air for 5 min before transfer to the cells. Sparging with N2 removed most of
the NO- from the solution and sparging with air converted residual NO. to HN02 and NO3-
(9). For [3H]TdR incorporation studies 4 x 106 cellswere treated with NO . as above, resus-
pended to 2 or 4 x 106 cells/ml in RPMI, plated at 5 x 104/well, and pulsed with [3H]TdR.
The NO .-saturated saline/glucose solutions that were used to treat cells for the [3H]TdR
studies were buffered with 25 mM succinate to prevent the pH from falling below 4.5 .
DigitoninPermeabilization ofL1210 Cells.
￿
This was done as described previously (10). NO.-
treated or control cells were washed twice by centrifugation in 30 ml cold respiration buffer
used for permeabilized cells (250 mM sucrose, 20 mM Hepes, 2 mm K2HPO4, 10 MM
MgC12, 1 mM EGTA, and 0.7% BSA, pH 7 .2), resuspended to 5 x 10' cells/ml, and treated
with digitonin (0.01%) for 10 min on ice. Tests with trypan blue dye exclusion showed each
cell preparation was <15% permeable before and >95% permeable after digitonin treatment.
The cells were centrifuged at 200 gfor 8 min at 4'C, washed once in 35 ml respiration buffer,
and resuspended to 108 cells/ml for 02 respiration measurements.
02 Respiration Measurements. 02 consumption was measured using a Clark electrode
(Yellow Springs Instrument Co., Yellow Springs, OH). For respiration measurements with
intact cells, L1210 cell suspensions (50 or 100 Al) were injected into a jacketed respirationchamber, which was kept at 370C and contained 1.4 ml Dulbecco's PBS (without Cat' or
Mg2') plus 25 mM glucose. L1210 respiration was calculated as the rate of decrease in 02
concentration following addition of cells, assuming an initial [02] = 390 ng/ml (11). Respi-
ration ofL1210 cells was dependent on glucose and 100% inhibitable by 3 mM KCN in all cases.
02 consumption by digitonin-permeabilized cells given mitochondrial substrates was mea-
sured as described previously (11). 50 or 100 ul ofcell suspensions were injected into a respira-
tion chamber containing 1.4 ml ofthe respiration buffer used for permeabilized cells (compo-
sition detailed above). After 3-5 min, a mitochondrial substrate was added in 10 pl to give
a final concentration of 5 mM for malate, succinate, or a-glycerophosphate (aglyPi), or 200
1,M for tetramethylphenylenediamine (TMPD). Rotenone (100 nM) inhibits electron flow
from complex 1 into the METC and was added in order to measure respiration on substrates
that donate electrons into the METC through complex 2 (succinate) or Coenzyme Q(aglyPi)
(11). For the same reason, antimycin A (40 nM) was added to block electron flow from Coen-
zyme Qinto the METC so that respiration on TMPD, which donates electrons to cytochrome
c, could be measured. State 3 respiration was initiated by adding 10 'al ADP (giving 1 mM)
and the rate of 02 consumption was calculated by subtracting the rate observed without sub-
trate from the state 3 rate. Cyanide (3 mM) completely blocked respiration on all substrates
except TMPD, where N15% of 02 consumption was not inhibitable. The cyanide-insensitive
value for each run that used TMPD was subtracted.
Measurement of (3HJTdR Incorporation by L1210 Cells.
￿
At the end of each incorporation
period, the 96-well culture plates were frozen and stored at -800C. [3H]TdR incorporation
was measured by liquid scintillation counting after processing the plates with an automatic
cell harvester (Dynatech, Wesbart, UK). Incorporation by cultures ofMO without L1210 was
determined for each experiment (typically 400-1,400 cpm) and subtracted from the coculture
values to obtain L1210-specific [3H]TdR uptake.
N02- and N03- Determination.
￿
N02- concentrations were determined by a microplate
assay that will be described in detail elsewhere (Stuehr, D. J., manuscript in preparation).
Briefly, 50- or 100-Al sample aliquots, diluted if needed, were mixed with an equal volume
of Griess reagent (l To sulfanilamide/0.1 % naphthylethylene diamine dihydrochloride/2 %
H3PO4) and incubated at room temperature for 10 min. The absorbance at 550 nm was mea-
sured in a microplate reader (BioTek Instruments, Inc., Burlington, VT). N02- was deter-
mined using NaN02 as a standard and double-distilled H2O as a blank. Background N02-
values ofbuffers or media were determined in each case and subtracted from the experimental
values. In certain cases the N02- and N03- concentrations were measured by an automated
method described elsewhere (12).
Results
Cytostasts Depends on a Process Associated with Mo N02-1N03- Synthesis but Is Not Due
to N02-IN03 or their Metabolites. Initial experiments showed that induction of MO
N02-/N03- synthesis by IFN-,y and LPS correlated closely with L1210 cytostasis
in coculture (Fig. 1) and that the cytostasis could be reversed 85% by a substrate-
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FIGURE 1.
￿
N02- synthesis (O) and
[3H]TdR uptake (0) by cocultures of
C3H/HeJ macrophages and L1210 cells
in the presence of 10,ug/ml LPS and
various concentrations of IFN-,y . LPS
and IFN-,y were added at the sametime
to cocultures, [3H]TdR was added 6 h
later, and the incorporation period was
12 h. The points represent the mean
t SD of four wells.1546
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based inhibitor of MO N02- synthesis, NMA (not shown). This confirmed a
previous report (6) that induction of the MO N02--producing pathway correlates
with and is required for cytostasis in this system. Since N02- can be growth inhibi-
tory (13-16), we tested ifexogenous NaN02 could cause cytostasis in the cocultures.
NaN03 served as a control. As shown in Table I, neither NaN02 nor NaN03 in-
hibited [3H]TdR incorporation in cultures containing 1,1210 cells and either nonac-
tivated or activated Mo (NMA was added to cocultures containing activated MO
to block conversion of1,-arginine to N02-/NO3"). N02- and N03- were ineffective
even when addedatconcentrations 50-foldhigher than those typicallyachieved under
coculture conditions (125 pM). Thus, activated Mo did not convert added N02-
or N03- into cytostatic agents .
Generation of Cytostatic Reactive Nitrogen Intermediates (RNI)from Acidification of N02- .
In bacterial systems (13-16), the cytostatic action of N02 increases upon mild
acidification through formation of nitrous acid (HN02, pKa 3.4) and its dismuta-
tion, which generates other RNI, including NO. and N02 (9, 17). Thus, we tested
ifacidified N02- solutions would inhibit replication of 1,1210 in the absence ofmac-
rophages. Fig. 2 shows that 1,1210 [3H]TdR incorporation was inhibited after cul-
ture with N02- under mildly acidic conditions. The degree of growth inhibition
wasdirectly proportional to the time ofexposure, the acidity, and the concentration
ofN02-, consistent with a requirement for formation ofHN02. At pH 6.2, a 10-h
exposure to 250 uM N02- (a concentration twice that typically achieved in acti-
vated Mo cultures) caused >50% cytostasis. Cytostasis did not occur when 1,1210
cells were cultured at these pH values in the absence of N02- (Fig. 2), nor when
N03- replaced N02- (not shown).
Cytostasis by NO. .
￿
Since RNI generated from acidified N02- were cytostatic, we
tested the effect of authentic NO. . Exposure to NO. for 5 min inhibited 1,1210
TABLE I
Inability of Added N02 - and N03 - to Inhibit
1,1210 Growth in MO Coculture
C3H/He Mo (105/well) were activated overnight with IFN--y (500 U/ml). Medi-
um was replaced the next day with an equal volume containing no LPS (con-
trol) or 2 Wg/ml LPS plus 250 pM NMA (activated). 1,1210 cells and 10 td of
NaN02 or NaN03 solutions were added. [3H]TdR was added 6 h later for an
18-h period. The experiment is representative of three and the values are the
mean cpm t SD offour wells. [3H]TdR incorporation in activated M0/1,1210
cocultures not receiving NMA was 1,208 ± 706 cptn 98% cytostasis). N02-
production (nmol/well) by cultures that did not receive [ H]TdR was 0.0 f 0.0,
control MO; 0.7 t 0.1, activated M46 + NMA; and 4.6 ± 0.1, activated Mrd
without NMA (n = 4).
1,1210 [3H]TdR incorporation
Control M¢ Activated Mo + NMA
Added N02-/NO3-
MM
N02- N03-
cpm x
N02-
10-3
N03
0 89 t2 - 79±0 -
1 93±8 96±2 62±3 78 f6
5 96 f 2 96 1 3 76 1 2 76 ± 7
10 99 t 11 84 t 13 88±5 78±420
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FIGURE 2. [3H]TdR incorporation by L1210 cells after culture for various times in N02--
containing medium at various pH. N02- concentrations were 0 (O), 0.25 (0), 0.5 (A), 1.0 (A),
and 2.5 mM (O). The experiment is representative of three and the values are the mean cpm
t SD for four cultures over an 18-h period.
[3H]TdR incorporation in a dose-dependent manner during a subsequent 3-h
labeling period, with an IC5o of -20 nmol NO-/106 cells (Fig. 3). Solutions that had
been rid of NO . by N2 sparging and aeration were incapable of causing cytostasis.
This indicated that the active principle was NO. and not its nonvolatile or oxygen-
resistant reaction products, such as N02-/NO3-. Maximal inhibition required NO.
exposures as short as 30 s; inhibition remained NO. specific through at least 10 min
of exposure (not shown). Thus, 5-min exposures were used routinely.
Recoveryfiom N0. -induced Cytostasis.
￿
Activated Mo cause target cell cytostasis within
8 h of coculture and it characteristically lasts 324 h (18, 19). Table II compares
[3H]TdR incorporation by L1210 cells rendered cytostatic either by treatment with
NO. or by 24-h coculture with activated Mo. DNA synthesis by L1210 cells in the
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first, second, and third 3-h periods after exposure to NO. was 22, 73, and 128%
of controls, respectively. In contrast, DNA synthesis by L1210 cells that had been
cocultured with activated Mo within the same three time periods was 12, 8, and
9% of controls. Recovery of[3H]TdR incorporation to the level ofcontrols for MO-
injuredcellswas not seen until30h (not shown). Thus, apulse ofNO. caused cytostasis
of shorter duration than that caused by cocultivation with activated MO for 24 h.
NO. -mediatedRespiratory Inhibition.
￿
Like cytostasis, inhibition oftarget cell respi-
ration by activated Mo is dependent on metabolism of L-arginine to N02-/NO3 -
(6). We therefore determined ifNO- could inhibit respiration ofL1210 cells in the
absence ofMo. Fig. 4 shows that NO- treatment inhibited cyanide-sensitive oxygen
uptake by L1210 cells in a dose-dependent manner, with an IC50 of66 nmol/107 cells.
The effect was NO, specific, since NO. solutions that had been sparged with N2
and aerated were inactive.
Sites ofN0. Injury within theMEW.
￿
M¢-mediated respiratory inhibition results
from specific injury within complex 1 (NADPH:ubiquinone oxidoreductase) and
complex 2 (succinate:ubiquinone oxidoreductase) ofthe METC (11). To determine
ifNO- exhibitedsimilarspecificity, NO.-treatedcellswere permeabilizedwithdigitonin
0
0 a
E
N
0
2.0
0.5
0.0
L1210 cells that were cocultured 24 h with CD-1 Mo or treated for 5 min with NO- solution
(625 nmol), N2-sparged/aerated NO- solution, or no solution (control), were plated at 5 x
104/well, and pulsed with [3H]TdR for the indicated periods. For L1210 cells harvested from
Mo plates, the resuspension and pulsing medium contained 250 UM NMA to prevent RNI
synthesis by activated MO that might be carried over in the washing step. The experiment
is representative of four and the values are the mean cpm ± SD of four cultures. The NO
solution had a pH of 5.4 and a N02- concentration of 4.1 mM . Mo N02- production over
the coculture period was 0.0 t 0.4 and 11 .7 ± 0.4 nmol/well for control and activated cul-
tures, respectively.
TABLE II
Timecourse of L1210 Recovery from MO- or NO- -induced Cytostasis
0 30 60 90 120 150
NO' (nmol/107 cells)
FIGURE 4.
￿
Dose-response curve for NO.
inhibition ofL1210 respiration on glucose.
Cells were treated for 5 min with various
amounts ofNO- solution (0) or NO- so-
lution that had been N2/air-sparged (0)
to remove NO- . The experiment shown
represents oneofseven. The points are the
mean t SD of three determinations.
Pulse period
h
NO-
L1210 [3H]TdR
Aerated NO -
incorporation
Control
cpm x 10-3
after exposure to:
Activated Mo Control MO
0-3 3 t 0 17 f 1 14 ± 1 3 t 1 27 t 2
3-6 25± 1 34±2 29±2 3 f0 42t 2
6-9 34 ± 3 26 f 11 30 ± 3 4 t 0 51 t 0and mitochondrial substrates were used to measure electron flow through complex
1 (malate), complex 2 (succinate), coenzyme Q(cxglyPi), and cytochrome c (TMPD).
NO- (40 nmol/10' cells) decreased L1210 cell respiration on malate or succinate to
16 and 44%, while respiration on ci-glycerophosphate or TMPD was 122 and 105%
ofcontrols, respectively (Table III). Thus, NO. specifically injured complex 1 and 2.
Scavenging ofMo-generatedN0- in Coculture.
￿
The above results indicated that NO.,
a Mo product, was capable ofcausing target cell cytostasis and respiratory inhibi-
tion. To test if NO. mediated these effects in MO-L1210 cell cocultures, we added
agents that scavenge NO- and monitored their effect on Mo-mediated cytostasis.
Superoxide reacts rapidly with NO. to produce the inactive product N03- (20). Fig.
5 depicts the effect ofa superoxide-generating system (FeS04/ascorbate; 21) on Mo-
mediated, L-arginine-dependent cytostasis. Catalase (1,000 U/ml)was addedto prevent
HOOH-mediated cytotoxicity to L1210 cells (22) that otherwise occurred when as-
corbate (1 mM) was present. Mo-induced cytostasis was partially prevented by the
superoxide-generating system. The antagonism was dependent on added Feel in
a concentration-dependent manner. Ascorbate alone was inactive, but greatly en-
hanced the ability ofFeel to prevent cytostasis at all Feel concentrations, presum-
ably by providing electrons for Fee'-catalyzed superoxide production (21). At 100
TABLE III
Sites of N0 - Injury Within the Mitochondrial Elecrlron Transport Chain
L1210 cells were treated for 5 min with NO - solution (48 nmol NO - /107 cells)
or an equivalent volume of N2-sparged/aerated NO - solution (pH 2.9, [N02_1
= 12 mM)and permeablized as described in Materials and Methods. Theex-
periment is representative of four and the values are the mean t SD of three
measurements. Values in parentheses are percents of the controls.
O
0 25 50 75 100
FeS04 (AM)
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FIGURE 5.
￿
Inhibition of activated Mo-
induced cytostasis by asuperoxide-gener-
ating system. [3H]TdR incorporation by
L1210 cells cocultured with activated M46
in the presence ofvarious concentrations
ofFeS04 alone (0), with 1 mM ascorbate
and 1,000 U/ml catalase (0), or with as-
corbate, catalase, and500U/ml SOD(O)
was measured over an 18-h period. The
experiment represents one of three. The
points are the mean cpm t SD for four
wells. Forcomparison, [3H]TdR incorpo-
ration by L1210 cells in cocultures con-
taining activated M¢ and 250,uM NMA
was 60,018 ± 1,678 cpm.
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Mitochondrial 02 consumption by
Substrate Acceptor Control
permeablized L1210 cells
NO - treated
ng 02/min/106 cells
Malate Complex 1 0.353 t 0.028 0.058 t 0.028 (16.4%)
Succinate Complex 2 0.694 ± 0.059 0.306 f 0.006 (44.1%)
a-GIyPi Coenzyme Q 0.398 t 0.039 0.486 t 0.030 (122%)
TMPD Cytochrome C 0.587 t 0.041 0.619 t 0.029 (105%)1550
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n
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FIGURE 6.
￿
Inhibition of activated Mo-
induced cytostasis by myoglobin. L1210
Y-
￿
cells were cultured with activated Mo and
various concentrations ofmyoglobinalone
O
￿
(A), myoglobinplus 1 mM ascorbateand
1,000U/ml catalase (0), ormyoglobinplus
ascorbate/catalase and 500 U/ml SOD
("). Results forL1210cultured with con-
trol M0, ascorbate/catalase, andvarying
amountsofmyoglobin(0)arealso shown.
Theexperiment represents oneofsix. The
points are the mean cpm t SD for four
wells. Forcomparison, [3H]TdR incorpo
2
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￿
ration by L1210 cells in cocultures con-
Myoglobin (mg/ml)
￿
taining activated Mo and 250 WM NMA
was 75,297 ± 2,683 cpm.
,uM FeS04 (plus ascorbate), L1210 DNA synthesis returned to 44% that of control
cocultures (L1210 cells and activated Mo given NMA). Inclusion of500 U/ml su-
peroxide dismutase (SOD) eliminated the protective effect of Fee+/ascorbate and
fully restored M¢-mediated cytostasis, while boiled SOD was inactive. Thus,
Fee+/ascorbate prevented Mo cytostasis primarily through generation of super-
oxide.
Ferroheme complexes suchasferrous myoglobinbind NO- withhigh affinity (23,
24) and have been used to scavenge NO. generated by endothelial cells (8, 25, 26)
and MO (7). The effect of a myoglobin NO.-scavenging system on MO-mediated
inhibition ofL1210 DNA synthesis is shown in Fig. 6. Myoglobin, when kept in the
ferrous state by inclusion of 1 mM ascorbate, blocked MO-mediated cytostasis of
cocultured L1210 cells in a dose-dependent manner. At 3 mg/ml myoglobin (plus
ascorbate), L1210 [3H]TdR incorporation recovered to 97% that ofcontrol (NMA-
treated) cocultures. Myoglobin was inactive in the absence ofthe reductant ascor-
bate; ascorbate alone was inactive. Inclusion of 500 U/ml SOD did not abrogate
scavenging byferrous myoglobin, consistent with a mechanism independent ofsuper-
oxide production.
Discussion
These results identify NO, (or N02, formed via reaction of NO- with 02) as an
L-arginine-derived Mo metabolite responsible for inhibition ofDNA synthesis and
mitochondrial respiration in L1210cells. Initial experiments (6), extended here, showed
that although metabolism of L-arginine was required for these effector functions,
the observed endproducts (N02- and NO3) were inactive. However, N02- became
cytostatic at acidic pH, a condition under which N02- is chemically converted into
more reactive species, including HN02, NO., and N02 (9, 17). During their me-
tabolism of L-arginine to N02-/NO3-, Mo produce a compound with biological,
biochemical, and physical properties of NO. or N02 (7). Authentic NO. inhibited
L1210 DNA synthesis and mitochondrial respiration in a dose-dependent manner.
Thepattern ofrespiratory injury wasstrikingly similartothat reported for activated
MO(11). Finally, systemsthat scavenge NO- (superoxideor ferrous myoglobin) par-
tially blocked Mo-mediated cytostasis in a coculture system.STUEHR AND NATHAN
￿
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NO--inducedlesions within the METC were restricted to complex 1 and 2. Com-
plex 1 and 2 contain several Fey clusters that may be susceptible to destruction by
both authentic and Mo-derived NO. and N02 (7, 27). In cell-free systems, NO-
reacts with certain FeS proteins, forming paramagnetic complexes similar to
Fe(NO)2(cysteine)2 (28). This suggests a molecular mechanism by which MO may
cause mitochondrial iron loss and respiratory inhibition (29).
Although apulse ofauthentic NO. inhibited target cell DNA synthesis in a rapid
and dose-dependent manner, its effect was shortlived compared with the cytostasis
caused by activated Mo or acidified N02-. Perhaps a sustained exposure to mod-
erate amounts of NO., as occurs during coculture with activated MO or during
acidification ofN02-, has a more lasting effect than a briefexposure to larger con-
centrations ofNO.. Alternatively, other RNI (such as HN02), may contribute. The
moleculartarget(s) involved inMo- orNO.-mediated cytostasis are unknown; thus,
itisnotyetpossibletocompare the treatments at the target level. Anenzyme catalyzing
the rate-limitingstepin DNA synthesis, ribonucleotide reductase, contains catalyti-
cally essentialnon-heme iron that iseasily removed(30). We areinvestigatingwhether
NO.-mediated inhibition of this enzyme is involved in Mo-induced cytostasis.
M-0 cytostasis was blocked 97% in the presence ofreduced myoglobin and 44%
in thepresence ofan Fe-catalyzedsuperoxide generating system. These systemsscav-
enge NO- and have been used to prevent its biological effects (8, 20, 24, 25). In
addition to scavenging NO., FeS04 and myoglobin may have helped injured cells
to recover faster from cytostasis by furnishing Feto replenish intracellularpools and
rebuild FeS clusters (10, 31). However, our findings that SOD reversed the Fee+/as-
corbate effect and that myoglobin was inactive unless reduced by ascorbate suggest
that increasedavailabilityofFe wasnot the mechanism bywhichcytostasiswas blocked.
NO. or acidified N02- have long been known to inhibit growth, respiration, and
active transport in fungi, bacteria, and bacteriophages (13-16). Molecular targets
include ferredoxins(7, 32), hydrogenases (33, 34), and glycolytic enzymesthat con-
tain essential sulfhydryl groups (35, 36). The ubiquitous distribution of these en-
zyme systemssuggeststhatMO-derived NO. may play a role inhost resistance against
a wide range of microbial pathogens.
The factors regulating cytotoxicity by Mo-derived NO. are not yet well under-
stood. For example, the flux ofNO- reaching a target willdepend on the concentra-
tions of species that can scavenge it, such as oxygen (9), superoxide (20), reduced
hemes (23, 24), transition metals (37), and thiols (38), as well as on the activity of
species that can protect NO-, such as superoxide dismutase (39). NO. bound to
certain transition metal complexes, as in nitroprusside, is sufficiently stable to be
used as a source ofslowly released NO. (37, 38, 40). Similarly, whilethiols can scav-
enge NO., resulting S-nitrosothiols can release it (38, 40).
The interrelationships between RNI and reactiveoxygen intermediates (ROI) are
also likely to be complex. Cytokines and bacterial products that induce production
ofRNI in Mo and those that enhance the capacity ofMO for release ofROI com-
prise overlapping but distinct sets (41). RNI release proceeds over -36 h after ex-
posure of Mo to activating signals alone (42-44). The respiratory burst is less de-
pendent on activatingsignals, but more dependent on additional triggering stimuli,
following which therelease ofROI usuallylasts <3 h(45). Although respiratory burst
products may inactivate NO., they can also deplete species that otherwise would1552
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scavenge or protect against NO., such as glutathione. Moreover, ROI may syner-
gize with RNI in mediatinginjury, particularly to FeS proteins involved in electron
transport (46). Also unknown is the subcellularlocation ofthe NO- synthetase (our
preliminary work suggests it is cytoplasmic) and whetherthere can be a directional
component to NO. release.
In biological systems, the distance over which NO. travels is probably limited by
its reaction with dissolved 02. This may explain why MO-mediated cytotoxicity
often requires proximity between Mo and target cells (47). N02- and N03-
(formed via decomposition ofMo-derived NO. and N02 in aqueous, oxygenated
environments) are relatively stable and could diffuse from the site ofNO- produc-
tion. Although N02- that entered the circulation would be oxidized to N03- by
oxyhemoglobin (48), anyportion entering acidic microenvironments, such as phago-
lysosomes, tumors, sites of infection, or exercising muscle, could reconvert to cyto-
toxic RNI through an acid-catalyzed reaction. This provides amechanism bywhich
RNI-related injury could occurat sites other than the point oforigin. Inpathologic
states with sustained production ofthe appropriate cytokines (41), such a process
might contribute to cachexia (49).
Summary
A metabolic pathway ofactivated macrophages (MO) involving oxidation of the
guanido nitrogens ofL-arginine is required for inhibition ofgrowth and respiration
of some target cells. The goal of this study was to identify the MO metabolite(s)
that induce these injuries. The stable products ofthe L-arginine pathway, N02- and
N03-, were incapable of causing cytostasis under coculture conditions. However,
N02- became cytostatic upon mild acidification, which favors its transformation
into nitrogen oxides of greater reactivity. This suggested that NO- (and/or N02),
recentlyidentified as an Mometabolite ofL-arginine, couldbe amediator. Authentic
NO- caused cytostasis and respiratory inhibition in L1210 cells in a dose-dependent
manner. The mitochondrial lesions caused by NO- were confined to complex 1 and
2, a pattern ofinjury identical to that seen aftercoculture with activated MO. Inclu-
sion ofNO. scavenger systems prevented cytostasis from developing in MO-L1210
cocultures. Thus, Mo-generated NO. canaccountforL-arginine-dependent cytostasis
and respiratory inhibition.
We thank Dr. Jack Peisach ofAlbert Einstein Medical College for helpful discussion, and
ClaudiaMorris andBonnie Thielforexpert assistance. IFN-.ywasa generousgiftofGenentech.
Receivedfor publication 21 December 1988.
Note added in proof: Evidence that Mo produce NO- was recently reported by two additional
laboratories (50, 51).
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